The Latest Cardiac and Vascular News
PARIS–(BUSINESS WIRE)–Sensome, formerly Instent, a company developing a revolutionary micro-sensor technology for smart medical devices out of France’s Ecole polytechnique, announced today that it has completed its €4.7m seed round to bring its first product to clinical trials. Venture capital firm Kurma Diagnostics led a syndicate with the new Paris-Saclay […]
IRVINE, Calif., July 11, 2017 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) (the “Company”), today announced preliminary results for its second quarter ended June 30, 2017. Reflecting accelerating utilization and an increasing number of ClearPoint sites, total revenue for the three months ended June 30, 2017 was $2.0 million, compared […]
FREMONT, Calif. and OXFORD, United Kingdom, July 6, 2017 /PRNewswire/ — Cerus Endovascular Ltd. today announced that it has received CE Mark approval for the commercial sale of its Contour Neurovascular System for the treatment of intra-cranial aneurysms (IAs) across the European Union (EU). The Contour Neurovascular System is a unique, fine mesh braid […]
ALAMEDA, Calif., July 5, 2017 /PRNewswire/ Penumbra, Inc. (NYSE: PEN) today announced that Daniel Davis has been promoted and will add the title of Chief Commercial Officer to his existing title of President, North America. Mr. Davis joined Penumbra in 2007 as one of the first members of the Company’s sales team and has advanced […]
NEW YORK, June 20, 2017 /PRNewswire/ — Mount Sinai Heart and BioImage-2 LLC, today announced start of the BioImage-2 study. The BioImage-2 study investigates the progression of vascular atherosclerotic plaque in patients who previously participated in the BioImage study. That landmark study recruited 7,687 volunteer participants from Humana members in Greater […]
VANCOUVER, June 15, 2017 /PRNewswire/ – Evasc Neurovascular Enterprises ULC announced that it has closed a CAD $10 million Series A venture capital financing round, led by Yonghua Investment Management Co., Ltd. (“Yonghua Capital”) of Shanghai, China. Several of Evasc’s existing investors also participated in the financing. Together with previous […]
TEL AVIV, ISRAEL–(Marketwired – June 05, 2017) – InspireMD, Inc. (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed an agreement with Arteriae Sp. z o.o. sp.k, a leading medical […]
TEL AVIV, ISRAEL–(Marketwired – June 02, 2017) – InspireMD, Inc. (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that Paul Stuka, who has served on the Company’s Board of Directors since 2011, […]
Press Release – InSpireMD BOSTON, MA—May 17, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced the publication of the Investigator Initiated IRON-GUARD Italian clinical registry in the peer reviewed journal EuroIntervention, which […]
FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) announces positive results from its REDUCE Study assessing closure of patent foramen ovale (PFO) for the reduction of recurrent ischemic stroke and new brain infarct. The data were shared May 16 at the European Stroke Organisation Conference (ESOC) in Prague, Czech […]
